Prevalence of anemia and dyslipidemia in patients with Diabetes Mellitus Type 2

Introduction: Diabetes is the leading cause of dyslipidemia and is associated with excessive cardiovascular morbidity and mortality. Anemia is common among those with diabetes and greatly contributes to patient outcomes. Observational studies indicate that low hemoglobin levels in such patients may increase risk for progression of kidney disease and cardiovascular morbidity and mortality in diabetic patients. Aim: The aim of the study was to find prevalence of anaemia and dyslipidemia in our population of patients with diabetes. Materials and methods: This was a descriptive analytical cross-sectional study carried out in GMERS Medical College and Hospital, Valsad. Total 100 consecutive patients with diabetes were enrolled and serum lipid profile, blood sugar estimation and complete blood count of all patients were done. All the results were noted and analysed statistically. Results: Anemia was present in 44% diabetic patients and 53% of the patients were dyslipidemics out of 100 patients in our study. Anemia and dyslipidemia were significantly higher in patients with diabetes, chronic kidney disease and diabetes with chronic kidney disease. Conclusion: Anemia and dyslipidemia was more prevalent in patients with diabetes and diabetes associated with chronic kidney disease. Correction of anemia may have a significant role in prevention of other diabetic complications.